Industry Focus
Healthcare: Eli Lilly’s Big Announcement, Plus GlaxoSmithKline Cozies Up to 23andMe
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:21:41
- Mas informaciones
Informações:
Sinopsis
It’s big pharma week! First, we discuss Eli Lilly’s second quarter earnings and its decision to spin-off its animal health business. Then, we explain why GlaxoSmithKline became an investor in the DNA screening company, 23andMe.
